In association  with

mapping

the mind

 Could personalised therapeutic intervention fingerprints help to predict the effectiveness of drugs?

 ISSUE 76 I NOVEMBER 2018

Gender in heart disease trials

Superpharmacies and the US drug industry

A decade of HPV prevention

06/06/2019 15:34:08
  • Home | Mapping the Mind
  • Wilhelm Haselmeier GmbH & Co KG Company Insight
  • Wilhelm Haselmeier GmbH & Co. KG
  • Editorial
  • Biocorp Company Insight
  • Biocorp
  • Contents
  • Fisher Clinical Services
  • Malvern Panalytical Company Insight
  • Malvern Panalytical
  • News
  • Gerteis Company Insight
  • Gerteis
  • The Pharma Industry Briefing
  • Mattler Toledo
  • Medelpharm
  • HPV vaccines: a decade of progress
  • Nipro PharmaPackaging
  • Pfanstiehl
  • Hereditary Alzheimer’s: could rare genes hold the clue to a cure?
  • SGS
  • Capsugel Company Insight
  • Capsugel
  • Could a unique brain fingerprint predict a drug’s effectiveness?
  • International Cannabis and Cannabinoid Institute (ICCI) Company Insight
  • International Cannabis and Cannabinoid Institute (ICCI)
  • Genetic studies: a powerful tool for testing combination therapies
  • Nelson Lab Company Insight
  • Nelson Lab
  • Abiogen Pharma
  • The Express Scripts story; super-pharmacies and the US drug industry
  • B Medical Systems
  • Daiichi Jitsugyo
  • Lauda
  • Is a lack of female participants skewing heart disease trial results?
  • Ecocool
  • HOF Sonderanlagenbau
  • Diversey
  • Why the German Centre for Diabetes Research changed its approach to handling data
  • Dow Europe GmbH Company Insight
  • Dow Europe GmbH
  • QualiMetriX
  • How digital innovation is helping to drive transformation in regulatory affairs
  • Dryce
  • ILC Dover Inc
  • Pall Biotech
  • Events
  • Event: Pharmpack Europe
  • Pharma Support Services Ltd Company Insight
  • Pharma Support Services Ltd
  • Unither Pharmaceuticals
  • Next issue
  • Butterworth
  • myLiquitab